49
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Pediatric EBV-positive T-cell/histiocyte-rich large B-cell lymphoma with clonal cells in the bone marrow without overt involvement

, , , &
Pages 465-469 | Published online: 01 Jul 2009

REFERENCES

  • De Wolf-Peeters C, Achten R. T-cell-rich large B-cell lymphoma-histiocyte-rich, T-cell-rich large B-cell lymphoma- T-cell/histiocyte-rich large B-cell lymphoma: will we ever see the wood for the trees? Histopathology 2002;41:269 –271.
  • Bouabdallah R, Mounier N, Guettier C, et al. T-cell/ histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J Clin Oncol 2003; 21:1271 – 1277.
  • Achten R, Verhoef G, Vanuytsel L, De Wolf-Peeters C. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 2002;40:31 – 45.
  • Lones MA, Cairo MS, Perkins SL. T-cell-rich large B-cell lymphoma in children and adolescents: a clinicopathologic report of six cases from the Children’s Cancer Group Study CCG-5961. Cancer 2000;88: 2378 – 2386.
  • Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin’s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989;7:186 – 193.
  • Ng CS, Chan JK, Hui PK, Lau WH. Large B-cell lymphomas with a high content of reactive T cells. Hum Pathol 1989;20:1145 – 1154.
  • Stenhammar L, Masreliez V. T-cell-rich B-cell lymphoma in a child with celiac disease. J Pediatr Gastroenterol Nutr 1993;17:337 – 338.
  • Greer JP, Macon WR, Lamar RE, et al. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J Clin Oncol 1995;13:1742 – 1750.
  • Camilleri-Broet S, Molina T, Audouin J, Tourneau AL, Diebold J. Morphological variability of tumour cells in T-cellrich B-cell lymphoma. A histopathological study of 14 cases. Virchows Arch 1996;429: 243 – 248.
  • Paulli M, Viglio A, Boveri E, et al. Nijmegen breakage syndrome-associated T-cell-rich B-cell lymphoma: case report. Pediatr Dev Pathol 2000;3:264 – 270.
  • Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988;12:433 – 443.
  • McBride JA, Rodriguez J, Luthra R, Ordonez NG, Cabanillas F, Pugh WC. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin’s disease. Am J Surg Pathol 1996;20:193 – 201.
  • Battig B, Mueller-Garamvoelgyi E, Cogliatti SB, et al. T-cellrich B-cell non-Hodgkin’s lymphoma mimicking Hodgkin’s disease. Leuk Lymphoma 1999;33:393 – 398.
  • Axdorph U, Porwit-Macdonald A, Sjoberg J, Grimfors G, Bjorkholm M. T-cell-rich B-cell lymphoma – diagnostic and therapeutic aspects. APMIS 2002;110:379 – 390.
  • Boudova L, Torlakovic E, Delabie J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 2003;102:3753 – 3758.
  • Murphy SB, Morgan ER, Katzenstein HM, Kletzel M. Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents. J Pediatr Hematol Oncol 2003;5:684 – 687.
  • La Starza R, Aventin A, Falzetti D, et al. 14q+ chromosome marker in a T-cell-rich B-cell lymphoma. J Pathol 1996;178:227 – 231.
  • Olney HJ, Gozzetti A, Rowley JD. Chromosomal abnormalities in childhood hematologic malignant disease. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski’s hematology of infancy and childhood. 6th ed. Philadelphia: W.B. Saunders Company; 2003. pp. 1101 – 1134.
  • Brauninger A, Kuppers R, Spieker T, et al. Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood 1999;93:2679 – 2687.
  • Skinnider BF, Connors JM, Gascoyne RD. Bone marrow involvement in T-cell-rich B-cell lymphoma. Am J Clin Pathol 1997;108:570 – 578. [21] Aboul-Nasr R, O’Brien S, Freireich EJ, et al. T-cell-rich Bcell lymphoproliferative disorder of the bone marrow. Leuk Lymphoma 2001;42: 1023 – 1031.
  • Ladetto M, Drandi D, Compagno M, et al. PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. J Clin Oncol 2003;21:1398 – 1403.
  • Lim MS, Beaty M, Sorbara L, et al. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol 2002;26:1458 – 1466.
  • Achten R, Verhoef G, Vanuytsel L, De Wolf-Peeters C. Tcell/ histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol 2002;20:1269 – 1277.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.